Supernus pharmaceuticals, inc. (SUPN)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Revenues
Total revenues

94,976

100,446

102,140

104,695

85,474

115,934

102,996

99,538

90,429

88,435

80,398

75,829

57,576

62,373

56,810

51,626

44,194

43,687

39,362

35,678

28,738

31,235

22,687

29,675

9,081

10,334

1,257

281

147

-

91

91

-

-

-

-

-

Costs and expenses
Cost of goods sold

4,152

4,113

4,819

4,044

3,684

4,188

4,207

3,683

3,278

4,154

4,251

3,861

2,949

3,772

3,428

2,751

2,035

2,795

2,248

1,762

1,618

2,282

1,321

1,661

494

-

33

4

-

-

-

-

-

-

-

-

-

Research and development

18,937

19,792

16,943

16,970

15,394

29,841

20,422

20,038

18,908

16,173

12,980

10,823

9,601

13,252

7,868

11,109

10,562

9,445

9,129

6,878

3,683

5,770

4,657

4,677

4,482

5,402

3,779

3,542

4,522

5,150

8,306

4,703

5,358

7,500

8,425

7,251

7,451

Selling, general and administrative

42,875

35,725

40,649

41,083

40,968

42,050

40,892

40,097

36,849

33,764

40,825

35,078

28,238

29,054

25,675

26,121

25,160

23,566

22,900

23,194

19,403

18,059

17,445

19,581

17,527

15,223

14,620

12,214

13,533

8,684

4,075

4,645

2,728

2,785

1,501

1,895

1,747

Total costs and expenses

65,964

59,630

62,411

62,097

60,046

76,079

65,521

63,818

59,035

54,091

58,056

49,762

40,788

46,078

36,971

39,981

37,757

35,806

34,277

31,834

24,704

26,111

23,423

25,919

22,503

21,692

18,432

15,760

18,055

13,834

12,381

9,348

8,086

10,285

9,926

9,146

9,198

Operating earnings

29,012

40,816

39,729

42,598

25,428

39,855

37,475

35,720

31,394

34,344

22,342

26,067

16,788

16,295

19,839

11,645

6,437

7,881

5,085

3,844

4,034

5,124

-736

3,756

-13,422

-11,358

-17,175

-15,479

-17,908

-12,744

-12,290

-9,257

-7,878

-10,243

-9,915

-8,396

-9,198

Other income (expense)
Interest expense

5,755

-

-

-

5,870

-

-

-

-

1,420

0

58

90

-34

202

196

179

225

292

331

381

1,189

1,289

1,278

1,207

2,108

2,870

2,144

727

804

880

929

962

508

499

499

360

Interest income, net

5,777

-

-

-

4,681

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

814

656

531

397

378

365

327

262

169

137

113

83

78

85

102

96

96

55

52

30

39

32

19

1

3

12

15

Interest expense on non-recourse liability related to sale of future royalties

-

-

-

-

-

-

-

-

-

-

155

160

959

984

1,004

1,281

1,279

1,011

998

773

759

-

326

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in fair value of derivative liabilities

-

-

-

-

-

-

-

-

-

-

-1

23

54

99

125

123

101

127

114

1

-49

694

760

678

677

-662

-4,153

-8,619

80

-

-294

-144

-

-

-

-

-

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-91

-103

-101

-289

0

0

-382

62

-25

-241

-2,134

0

-860

-39

-1,693

-

-

-1,162

-

-

-

-

-

-

-

-

-

Total other income (expense)

22

96

-139

148

-1,189

-1,088

-1,104

-1,864

-212

-

-

-

-

-

-

-

-

-

5

25

-

-

2

-

-

14

6

-8

89

278

-57

285

-456

171

260

-57

-172

Total other income (expense)

-

-

-

-

-

-

-

-

-

-

568

358

-565

-743

-703

-989

-1,412

-815

-1,027

-1,182

-3,210

-707

-1,635

-554

-2,121

-11,048

-6,921

-11,878

-506

-768

-1,192

-756

-1,399

-421

-236

-544

-517

Earnings before income taxes

29,034

40,912

39,590

42,746

24,239

38,767

36,371

33,856

31,182

35,060

22,910

26,425

16,223

15,552

19,136

10,656

5,025

7,066

4,058

2,662

824

4,417

-2,371

3,202

-15,543

-

-

-

-

-

-

-

-

-

-

-

-

Income tax expense

7,516

7,783

10,730

10,019

5,899

12,874

8,360

3,119

4,830

21,402

6,949

9,057

5,926

1,233

-42,690

405

200

213

142

225

86

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,581

-10,151

-8,940

-9,715

Income from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

76,394

417

1,563

-1,334

Net earnings

21,518

33,129

28,860

32,727

18,340

25,893

28,011

30,737

26,352

13,658

15,961

17,368

10,297

14,319

61,826

10,251

4,825

6,853

3,916

2,437

738

3,787

-2,371

3,202

-15,543

-22,406

-24,096

-27,357

-18,414

-13,512

-13,482

-10,013

-9,277

81,975

-9,734

-7,377

-11,049

Cumulative dividends on Series A convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-1

286

858

856

858

858

858

Net income (loss) attributable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-13,511

-13,482

-10,299

-10,135

81,119

-10,592

-8,235

-11,907

Basic and diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

30,875

-

24,464

16,817

1,676

-

1,595

-

-

Earnings per share
Basic (in dollars per share)

0.41

0.64

0.55

0.62

0.35

0.49

0.54

0.59

0.51

0.27

0.31

0.34

0.21

0.28

1.25

0.21

0.10

0.14

0.08

0.05

0.02

0.10

-0.06

0.08

-0.38

-

-0.78

-0.89

-

-

-

-

-

-

-

-

-

Diluted (in dollars per share)

0.40

0.61

0.54

0.61

0.34

0.47

0.52

0.57

0.49

0.28

0.29

0.32

0.19

0.32

1.18

0.18

0.08

0.14

0.08

0.04

0.02

0.10

-0.06

0.08

-0.38

-

-0.78

-0.89

-

-

-

-

-

-

-

-

-

Net (loss) income per common share:
Continuing operations (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3.09

-6.90

-6.15

-6.64

Discontinued operations (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

47.59

0.26

0.98

-0.84

Basic and diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.60

-

-0.55

-0.61

-6.05

50.68

-6.64

-5.17

-7.48

Weighted-average shares outstanding
Basic (in shares)

52,534

52,473

52,453

52,385

52,336

52,275

52,227

51,919

51,536

51,290

51,046

50,530

50,158

49,705

49,516

49,427

49,240

48,950

48,515

47,911

44,563

42,957

42,900

42,056

41,129

-

30,941

30,897

-

-

-

-

-

-

-

1,594

1,592

Diluted (in shares)

53,581

53,562

53,805

53,912

53,985

54,163

54,239

54,203

53,788

53,588

53,628

53,223

52,764

51,964

51,974

51,745

51,152

55,875

51,590

52,273

44,901

42,642

42,900

42,372

41,129

-

30,941

30,897

-

-

-

-

-

-

-

1,594

1,592

Net product sales
Total revenues

92,490

97,909

100,034

102,358

83,099

113,494

100,227

97,030

89,120

86,334

78,066

73,328

56,369

61,100

55,618

50,335

43,025

42,612

38,551

34,266

28,097

30,515

22,452

27,609

8,995

-

1,130

154

-

-

-

-

208

-

11

750

-

Royalty revenues
Total revenues

2,486

2,537

2,106

2,337

2,375

2,440

2,769

1,758

1,309

2,029

2,010

1,179

1,149

1,222

1,140

1,205

1,119

1,031

776

626

605

-

199

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Licensing revenue
Total revenues

-

-

0

0

-

-

0

750

-

72

322

1,322

58

51

52

86

50

44

35

786

36

286

36

2,066

86

66

127

127

147

-

91

91

-

-

-

750

-